We are live on ! Find out more
FOLD

Amicus Therapeutics
FOLD

Delisted

FOLD was delisted on the 24th of April, 2026.

Back to rankings

68 hedge funds and large institutions have $71M invested in Amicus Therapeutics in 2014 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 27 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

268% more call options, than puts

Call options by funds: $140K | Put options by funds: $38K

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

1% less funds holding

Funds holding: 69 → 68 (-1)

12% less capital invested

Capital invested by funds: $81.1M → $71M (-$10M)

37% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 27

Holders
68
Holders Change
-1
Holders Change %
-1.45%
% of All Funds
1.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
17
Reduced
27
Closed
7
Calls
$140K
Puts
$38K
Net Calls
+$102K
Net Calls Change
-$112K

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$2.42M
2
SGAM
Smith Group Asset Management
Texas
+$669K
3
TI
Turner Investments
Pennsylvania
+$632K
4
OAM
Oxford Asset Management
United Kingdom
+$260K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$134K

Top Sellers

Rank Fund Capital Flow
1
TC
TFS Capital
Pennsylvania
-$1.14M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$795K
3
Renaissance Technologies
Renaissance Technologies
New York
-$696K
4
IHM
Iguana Healthcare Management
New York
-$623K
5
RG
Redmile Group
California
-$379K
Name Holding Trade Value Shares
Change 		Change in
Stake
TC
26
TFS Capital
Pennsylvania
$271K -$1.14M -455,775 -78%
TCIM
27
TIAA CREF Investment Management
New York
$256K – – –
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$252K – – –
BCM
29
Bridgeway Capital Management
Texas
$251K – – –
Renaissance Technologies
30
Renaissance Technologies
New York
$250K -$696K -278,401 -70%
PAAMCP
31
Pacific Alternative Asset Management Company (PAAMCO)
California
$227K -$209K -83,776 -43%
OAM
32
Oxford Asset Management
United Kingdom
$216K +$260K +104,166 New
Axa
33
Axa
France
$202K +$8.3K +3,319 +4%
BIM
34
BlackRock Investment Management
Delaware
$181K -$3.06K -1,223 -1%
CS
35
Credit Suisse
Switzerland
$165K +$5.17K +2,068 +3%
AllianceBernstein
36
AllianceBernstein
Tennessee
$163K -$9.25K -3,700 -4%
Charles Schwab
37
Charles Schwab
California
$115K – – –
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$113K – – –
PRHC
39
P.R. Herzig & Co
New York
$110K – – –
Two Sigma Investments
40
Two Sigma Investments
New York
$106K +$81.5K +32,587 +174%
BIP
41
Brandes Investment Partners
California
$100K +$120K +48,100 New
TA
42
Teachers Advisors
New York
$93K – – –
Goldman Sachs
43
Goldman Sachs
New York
$91K -$21.2K -8,476 -16%
Brown Advisory
44
Brown Advisory
Maryland
$66K – – –
ProShare Advisors
45
ProShare Advisors
Maryland
$64K +$77K +30,782 New
BA
46
BlackRock Advisors
Delaware
$60K +$9.91K +3,964 +16%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$57K -$2.55K -1,020 -4%
SIP
48
Stoneridge Investment Partners
Pennsylvania
$51K -$1.75K -700 -3%
NFA
49
Nationwide Fund Advisors
Ohio
$51K – – –
State Board of Administration of Florida Retirement System
50
State Board of Administration of Florida Retirement System
Florida
$50K – – –
1
2
3

FOLD Hedge Fund Activity: Q1 2014 in Review

68 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q1 2014, worth a combined $71M — down 12% from $81.1M a quarter earlier.

Fund positioning in FOLD was balanced in Q1 2014: 7 funds opened new positions, 7 closed out, 17 added to existing stakes and 27 trimmed.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $2.42M. The largest seller was TFS Capital, cutting an estimated $1.14M.

  • 68 institutional investors held Amicus Therapeutics (FOLD) as of Q1 2014, down from 69 in Q4 2013.
  • Funds reported $71M of Amicus Therapeutics stock for Q1 2014, down 12% quarter-over-quarter.
  • 7 funds opened new Amicus Therapeutics positions in Q1 2014 and 7 closed out, a net change of 0 holders.
  • The largest Amicus Therapeutics buyer in Q1 2014 was Perceptive Advisors, an estimated $2.42M added.
  • The largest Amicus Therapeutics seller in Q1 2014 was TFS Capital, an estimated $1.14M sold.

Based on aggregated 13F filings for Q1 2014.